Início › Doenças Pulmonares Intersticiais › Kansas › Kansas City
Ensaios clínicos de Doenças Pulmonares Intersticiais em Kansas City, KS
13 estudos para Doenças Pulmonares Intersticiais estão buscando participantes em locais em Kansas City e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
RecrutandoFase 3
- University of Kansas Medical Center, Kansas City
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
RecrutandoFase 3
- University of Kansas Medical Center, Kansas City
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
RecrutandoFase 3
- USA002, Kansas City
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
RecrutandoFase 2
- University of Kansas Medical Center, Kansas City
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
RecrutandoFase 2
- Clinical Research Site, Kansas City
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
RecrutandoEstudo observacional
- University of Kansas Medical Center, Kansas City
Platform Clinical Study for Conquering Scleroderma
RecrutandoFase 2
- University of Kansas School of Medicine, Kansas City
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
RecrutandoFase 2/3
- University of Kansas Medical Center, Kansas City
A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
RecrutandoFase 2
- The University of Kansas Medical Center Research Institute, Kansas City
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
RecrutandoFase 3
- University of Kansas Medical Center, Kansas City
Interstitial Lung Disease Research Unit Biobank
RecrutandoEstudo observacional
- The University of Kansas Medical Center, Kansas City
Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease
RecrutandoFase 1Voluntários saudáveis bem-vindos
- University of Kansas Medical Center, Kansas City
Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease
RecrutandoEstudo observacional
- University of Kansas, Kansas City
Ensaios de Doenças Pulmonares Intersticiais em outras cidades
- New York City, NY18 estudos
- Philadelphia, PA16 estudos
- Los Angeles, CA14 estudos
- Charleston, SC13 estudos
- Durham, NC13 estudos
- Chicago, IL12 estudos
- Houston, TX12 estudos
- Aurora, CO11 estudos
- Ann Arbor, MI11 estudos
- Dallas, TX9 estudos
- Salt Lake City, UT9 estudos
- Boston, MA9 estudos
Outros estudos em Kansas City
- Doença Cardiovascular14 estudos
- Insuficiência Cardíaca13 estudos
- Obesidade13 estudos
- Fibrose Cística13 estudos
- Câncer de Mama12 estudos
- Câncer de Bexiga12 estudos
- Leucemia Mieloide Aguda12 estudos
- Câncer de Próstata12 estudos
- Câncer de Pulmão de Não Pequenas Células11 estudos
- Câncer de Pulmão11 estudos
- DPOC9 estudos
- Asma8 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.